Literature DB >> 30120899

Lathyrane-Type Diterpenoids from the Seeds of Euphorbia lathyris L. with Inhibitory Effects on NO Production in RAW 264.7 Cells.

Jin Woo Lee1, Qinghao Jin1, Hari Jang1, Jun Gu Kim1, Dongho Lee2, Youngsoo Kim1, Jin Tae Hong1, Mi Kyeong Lee1, Bang Yeon Hwang1.   

Abstract

Bioactivity-guided fractionation of the methanolic extract from the seeds of Euphorbia lathyris led to the isolation of 18 lathyrane-type diterpenoids including a new one, Euphorbia factor L29 (1). Their chemical structures were elucidated by extensive NMR spectroscopic data including 2D-NMR and HR-ESI-MS as well as CD data. All isolates (1 - 18) were found to inhibit the nitric oxide production in LPS-induced RAW 264.7 macrophages, with their IC50 values in the range of 11.2 - 52.2 μm.
© 2018 Wiley-VHCA AG, Zurich, Switzerland.

Entities:  

Keywords:  zzm321990Euphorbia lathyriszzm321990; Euphorbiaceae; anti-inflammatory activities; lathyrane-type diterpenoids; nitric oxide

Mesh:

Substances:

Year:  2018        PMID: 30120899     DOI: 10.1002/cbdv.201800144

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  3 in total

1.  Bioactive diterpenoid metabolism and cytotoxic activities of genetically transformed Euphorbia lathyris roots.

Authors:  Vincent A Ricigliano; Vincent P Sica; Sonja L Knowles; Nicole Diette; Dianella G Howarth; Nicholas H Oberlies
Journal:  Phytochemistry       Date:  2020-09-25       Impact factor: 4.072

2.  Two lathyrane diterpenoid stereoisomers containing an unusual trans-gem-dimethylcyclopropane from the seeds of Euphorbia lathyris.

Authors:  Linwei Li; Jianan Huang; Hui Lyu; Fuqin Guan; Pirui Li; Mei Tian; Shu Xu; Xingzeng Zhao; Fei Liu; Christian Paetz; Xu Feng; Yu Chen
Journal:  RSC Adv       Date:  2021-01-14       Impact factor: 3.361

Review 3.  Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources.

Authors:  Fátima Vela; Abdellah Ezzanad; Alan Christy Hunter; Antonio José Macías-Sánchez; Rosario Hernández-Galán
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.